DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells

Epigenetics

Volumn 7, Issue 6, 2012, Pages 635-651

  Thaler, Roman ^a   Spitzer, Silvia ^a   Karlic, Heidrun ^a   Klaushofer, Klaus ^a   Varga, Franz ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Apoptosis; Dimethylsulfoxide; DNA hydroxymethylation; DNA methylation; Osteoblasts

Indexed keywords

5 METHYLCYTOSINE; CASPASE 3; CASPASE 7; CASPASE 8; DIMETHYL SULFOXIDE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MESSENGER RNA; TRANSCRIPTION FACTOR DLX5;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA HYDROXYMETHYLATION; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVITY; EUCHROMATIN; EXCISION REPAIR; EXTRACELLULAR MATRIX; FAS GENE; GENE; GENE EXPRESSION; GENE REPLICATION; HELLS GENE; MOUSE; NONHUMAN; OSTEOBLAST; PROMOTER REGION; TET1 GENE; TET2 GENE; UPREGULATION;

EID: 84861947966     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.20163     Document Type: Article

References (67)

1. Varga F, Karlic H, Thaler R, Klaushofer K. Functional aspects of CpG dinucleotides and their locations in genes. BioMolecular Concepts 2011; 286:5578-88.
2. Razin A, Webb C, Szyf M, Yisraeli J, Rosenthal A, Naveh-Many T, et al. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci USA 1984; 81:2275-9. PMID:6585800; http://dx.doi.org/10.1073/pnas.81.8.2275.
3. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-13. PMID:2423876; http://dx.doi.org/10.1038/321209a0.
4. Gazin C, Wajapeyee N, Gobeil S, Virbasius CM, Green MR. An elaborate pathway required for Rasmediated epigenetic silencing. Nature 2007; 449:1073-7. PMID:17960246; http://dx.doi.org/10.1038/nature06251.
5. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9:2395-402. PMID:11005794; http://dx.doi.org/10.1093/hmg/9.16.2395.
6. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 1999; 397:579-83. PMID:10050851; http://dx.doi.org/10.1038/17533.
7. Barreto G, Schäfer A, Marhold J, Stach D, Swaminathan SK, Handa V, et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 2007; 445:671-5. PMID:17268471; http://dx.doi.org/10.1038/nature05515.
8. Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase and gadd45. Cell 2008; 135:1201-12. PMID:19109892; http://dx.doi.org/10.1016/j.cell.2008.11.042.
9. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011; 145:423-34. PMID:21496894; http://dx.doi.org/10.1016/j.cell.2011.03.022.
10. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5 hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466:1129-33. PMID:20639862; http://dx.doi.org/10.1038/nature09303.
11. Wu H, Zhang Y. Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells. Cell Cycle 2011; 10:2428-36. PMID:21750410; http://dx.doi.org/10.4161/cc.10.15.16930.
12. Ma DK, Guo JU, Ming GL, Song H. DNA excision repair proteins and Gadd45 as molecular players for active DNA demethylation. Cell Cycle 2009; 8:1526-31. PMID:19377292; http://dx.doi.org/10.4161/cc.8.10.8500.
13. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011; 473:398-402. PMID:21460836; http://dx.doi.org/10.1038/nature10008.
14. Wu H, D'Alessio AC, Ito S, Xia K, Wang Z, Cui K, et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011; 473:389-93. PMID:21451524; http://dx.doi.org/10.1038/nature09934.
15. Iwatani M, Ikegami K, Kremenska Y, Hattori N, Tanaka S, Yagi S, et al. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells 2006; 24:2549-56. PMID:16840553; http://dx.doi.org/10.1634/stemcells.2005-0427.
16. Friend C, Scher W, Holland JG, Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci USA 1971; 68:378-82. PMID:5277089.
17. Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007; 25:84-90. PMID:17211407; http://dx.doi.org/10.1038/nbt1272.
18. Pruitt SC. Discrete endogenous signals mediate neural competence and induction in P19 embryonal carcinoma stem cells. Development 1994; 120:3301-12. PMID:7536654.
19. Dinsmore J, Ratliff J, Deacon T, Pakzaban P, Jacoby D, Galpern W, et al. Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant 1996; 5:131-43. PMID:8689027; http://dx.doi.org/10.1016/0963-6897(95)02040-3.
20. Bonser RW, Siegel MI, McConnell RT, Cuatrecasas P. The appearance of phospholipase and cyclo-oxygenase activities in the human promyelocytic leukemia cell line HL60 during dimethyl sulfoxide-induced differentiation. Biochem Biophys Res Commun 1981; 98:614-20. PMID:6261745; http://dx.doi.org/10.1016/0006-291X(81)91158-X.
21. Yokochi T, Robertson KD. Dimethyl sulfoxide stimulates the catalytic activity of de novo DNA methyltransferase 3a (Dnmt3a) in vitro. Bioorg Chem 2004; 32:234-43. PMID:15210338; http://dx.doi.org/10.1016/j.bioorg.2004.04.005.
22. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7. PMID:10102814; http://dx.doi.org/10.1126/science.284.5411.143.
23. Kim YJ, Kim BG, Lee SJ, Lee HK, Lee SH, Ryoo HM, et al. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. J Cell Physiol 2007; 211:253-60. PMID:17167770; http://dx.doi.org/10.1002/jcp.20933.
24. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006; 99:1233-9. PMID:16795049; http://dx.doi.org/10.1002/jcb.20958.
25. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, et al. BMP-2-induced Runx2 expression is mediated by Dlx5 and TGF-beta1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003; 278:34387-94. PMID:12815054; http://dx.doi.org/10.1074/jbc.M211386200.
26. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006; 7:1-16. PMID:17051438; http://dx.doi.org/10.1007/s11154-006-9001-5.
27. Ryoo HM, Lee MH, Kim YJ. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006; 366:51-7. PMID:16314053; http://dx.doi.org/10.1016/j.gene.2005.10.011.
28. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96:191-8. PMID:6826647; http://dx.doi.org/10.1083/jcb.96.1.191.
29. Luegmayr E, Varga F, Frank T, Roschger P, Klaushofer K. Effects of triiodothyronine on morphology, growth behavior and the actin cytoskeleton in mouse osteoblastic cells (MC3T3-E1). Bone 1996; 18:591-9. PMID:8806001; http://dx.doi.org/10.1016/8756-3282(96)00068-3.
30. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96:191-8. PMID:6826647; http://dx.doi.org/10.1083/jcb.96.1.191.
31. Fratzl-Zelman N, Fratzl P, Hörandner H, Grabner B, Varga F, Ellinger A, et al. Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. Bone 1998; 23:511-20. PMID:9855459; http://dx.doi.org/10.1016/S8756-3282(98)00139-2.
32. Fratzl-Zelman N, Hörandner H, Luegmayr E, Varga F, Ellinger A, Erlee MP, et al. Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. Bone 1997; 20:225-36. PMID:9071473; http://dx.doi.org/10.1016/S8756-3282(96)00367-5.
33. Stephens AS, Stephens SR, Hobbs C, Hutmacher DW, Bacic-Welsh D, Woodruff MA, et al. Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization. J Biol Chem 2011; 286:30071-86. PMID:21652706; http://dx.doi.org/10.1074/jbc.M111.253518.
34. Thaler R, Karlic H, Spitzer S, Klaushofer K, Varga F. Extra-cellular matrix suppresses expression of the apoptosis mediator Fas by epigenetic DNA methylation. Apoptosis 2010; 15:728-37. PMID:20428952; http://dx.doi.org/10.1007/s10495-010-0462-3.
35. Zhang RP, Shao JZ, Xiang LX. GADD45A protein plays an essential role in active DNA demethylation during terminal osteogenic differentiation of adipose-derived mesenchymal stem cells. J Biol Chem 2011; 286:41083-94. PMID:21917922; http://dx.doi.org/10.1074/jbc.M111.258715.
36. Schweizer D. Counterstain-enhanced chromosome banding. Hum Genet 1981; 57:1-14. PMID:6167505.
37. Schwarzacher-Robinson T, Cram LS, Meyne J, Moyzis RK. Characterization of human heterochromatin by in situ hybridization with satellite DNA clones. Cytogenet Cell Genet 1988; 47:192-6. PMID:3416653; http://dx.doi.org/10.1159/000132547.
38. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17:1675-87. PMID:9501089; http://dx.doi.org/10.1093/emboj/17.6.1675.
39. Movassagh M, Foo RS. Simplified apoptotic cascades. Heart Fail Rev 2008; 13:111-9. PMID:18080749; http://dx.doi.org/10.1007/s10741-007-9070-x.
40. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003; 278:40967-72. PMID:12881513; http://dx.doi.org/10.1074/jbc.M307380200.
41. Cheung WM, Ng WW, Kung AW. Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3-E1 cells. FEBS Lett 2006; 580:121-6. PMID:16360153; http://dx.doi.org/10.1016/j.febslet.2005.11.062.
42. Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007; 25:84-90. PMID:17211407; http://dx.doi.org/10.1038/nbt1272.
43. Jones CL, Wain EM, Chu CC, Tosi I, Foster R, McKenzie RC, et al. Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation. J Invest Dermatol 2010; 130:1116-25. PMID:19759548; http://dx.doi.org/10.1038/jid.2009.301.
44. Karabulut B, Karaca B, Atmaca H, Kisim A, Uzunoglu S, Sezgin C, et al. Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines. Mol Biol Rep 2011; 38:249-59. PMID:20349282; http://dx.doi.org/10.1007/s11033-010-0102-6.
45. Patra SK, Szyf M. DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A. FEBS J 2008; 275:5217-35. PMID:18803665; http://dx.doi.org/10.1111/j.1742-4658.2008.06658.x.
46. Petak I, Danam RP, Tillman DM, Vernes R, Howell SR, Berczi L, et al. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma. Cell Death Differ 2003; 10:211-7. PMID:12700649; http://dx.doi.org/10.1038/sj.cdd.4401132.
47. Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 2010; 11:607-20. PMID:20683471; http://dx.doi.org/10.1038/nrm2950.
48. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324:929-30. PMID:19372393; http://dx.doi.org/10.1126/science.1169786.
49. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930-5. PMID:19372391; http://dx.doi.org/10.1126/science.1170116.
50. Matrisciano F, Dong E, Gavin DP, Nicoletti F, Guidotti A. Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain. Mol Pharmacol 2011; 80:174-82. PMID:21505039; http://dx.doi.org/10.1124/mol.110.070896.
51. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9:2395-402. PMID:11005794; http://dx.doi.org/10.1093/hmg/9.16.2395.
52. Myant K, Stancheva I. LSH cooperates with DNA methyltransferases to repress transcription. Mol Cell Biol 2008; 28:215-26. PMID:17967891; http://dx.doi.org/10.1128/MCB.01073-07.
53. Sun LQ, Lee DW, Zhang Q, Xiao W, Raabe EH, Meeker A, et al. Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG. Genes Dev 2004; 18:1035-46. PMID:15105378; http://dx.doi.org/10.1101/gad.1176104.
54. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011; 8:200-13. PMID:21295276; http://dx.doi.org/10.1016/j.stem.2011.01.008.
55. Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, et al. Genetic characterization of TET1, TET2 and TET3 alterations in myeloid malignancies. Blood 2009; 114:144-7. PMID:19420352; http://dx.doi.org/10.1182/blood-2009-03-210039.
56. GK. Leukaemia and lymphoma: The expansive reach of TET2. Nat Rev Cancer 2011; 11:535. PMID:21779006; http://dx.doi.org/10.1038/nrc3115.
57. Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011; 20:11-24. PMID:21723200; http://dx.doi.org/10.1016/j.ccr.2011.06.001.
58. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, Rappsilber J, et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011; 473:343-8. PMID:21490601; http://dx.doi.org/10.1038/nature10066.
59. Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011; 473:394-7. PMID:21552279; http://dx.doi.org/10.1038/nature10102.
60. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011; 145:423-34. PMID:21496894; http://dx.doi.org/10.1016/j.cell.2011.03.022.
61. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21:115-37. PMID:10782361; http://dx.doi.org/10.1210/er.21.2.115.
62. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 1999; 14:893-903. PMID:10352097; http://dx.doi.org/10.1359/jbmr.1999.14.6.893.
63. Tamura Y, Takeuchi Y, Suzawa M, Fukumoto S, Kato M, Miyazono K, et al. Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 2001; 16:1772-9. PMID:11585340; http://dx.doi.org/10.1359/jbmr.2001.16.10.1772.
64. Guryanova O, Levine R. DNMT3A and stem cell function: new insights into old pathways. Haematologica 2012; 97:324. PMID:22383741; http://dx.doi.org/10.3324/haematol.2012.064410.
65. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:45. PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45.
66. Anisowicz A, Huang H, Braunschweiger KI, Liu Z, Giese H, Wang H, et al. A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer 2008; 8:222. PMID:18673580; http://dx.doi.org/10.1186/1471-2407-8-222.
67. Varga F, Rumpler M, Luegmayr E, Fratzl-Zelman N, Glantschnig H, Klaushofer K. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun and induction of osteocalcin expression. Calcif Tissue Int 1997; 61:404-11. PMID:9351883; http://dx.doi.org/10.1007/s002239900356.